suspensões injetáveis

a presente invenção refere-se a suspensões assépticas, fisicamente estáveis e injetáveis através de uma agulha de 25g ou mais fina, compreendendo partículas de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalinas, não micronizadas, uma mistura de acilgliceróis e colesterol, processos para a preparação d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KAROL HORVATH, BJÖRN NORRLIND, MAGNUS BRISANDER
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KAROL HORVATH
BJÖRN NORRLIND
MAGNUS BRISANDER
description a presente invenção refere-se a suspensões assépticas, fisicamente estáveis e injetáveis através de uma agulha de 25g ou mais fina, compreendendo partículas de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalinas, não micronizadas, uma mistura de acilgliceróis e colesterol, processos para a preparação de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalina, não micronizada, adequada para tais suspensões, assim como métodos para a fabricação de tais suspensões. The present invention relates to aseptic suspensions, physically stable and injectable through a 25 G needle or thinner, comprising crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols and cholesterol, processes for preparing crystalline, non-micronized, 3-beta-hydroxy-5-alpha-pregnan-20-one suitable for such suspensions, as well as methods for manufacturing such suspensions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112019012959A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112019012959A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112019012959A23</originalsourceid><addsrcrecordid>eNrjZBAvLi0uSM0rPrw1tVghMy8rteTwwrLUzGIeBta0xJziVF4ozc2g6uYa4uyhm1qQH59aXJCYnJqXWhLvFGRoaGRgaGlgaGRpauloZEysOgCZ6yVW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>suspensões injetáveis</title><source>esp@cenet</source><creator>KAROL HORVATH ; BJÖRN NORRLIND ; MAGNUS BRISANDER</creator><creatorcontrib>KAROL HORVATH ; BJÖRN NORRLIND ; MAGNUS BRISANDER</creatorcontrib><description>a presente invenção refere-se a suspensões assépticas, fisicamente estáveis e injetáveis através de uma agulha de 25g ou mais fina, compreendendo partículas de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalinas, não micronizadas, uma mistura de acilgliceróis e colesterol, processos para a preparação de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalina, não micronizada, adequada para tais suspensões, assim como métodos para a fabricação de tais suspensões. The present invention relates to aseptic suspensions, physically stable and injectable through a 25 G needle or thinner, comprising crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols and cholesterol, processes for preparing crystalline, non-micronized, 3-beta-hydroxy-5-alpha-pregnan-20-one suitable for such suspensions, as well as methods for manufacturing such suspensions.</description><language>por</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PERFORMING OPERATIONS ; PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SEPARATION ; STEROIDS ; TRANSPORTING</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191126&amp;DB=EPODOC&amp;CC=BR&amp;NR=112019012959A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191126&amp;DB=EPODOC&amp;CC=BR&amp;NR=112019012959A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KAROL HORVATH</creatorcontrib><creatorcontrib>BJÖRN NORRLIND</creatorcontrib><creatorcontrib>MAGNUS BRISANDER</creatorcontrib><title>suspensões injetáveis</title><description>a presente invenção refere-se a suspensões assépticas, fisicamente estáveis e injetáveis através de uma agulha de 25g ou mais fina, compreendendo partículas de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalinas, não micronizadas, uma mistura de acilgliceróis e colesterol, processos para a preparação de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalina, não micronizada, adequada para tais suspensões, assim como métodos para a fabricação de tais suspensões. The present invention relates to aseptic suspensions, physically stable and injectable through a 25 G needle or thinner, comprising crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols and cholesterol, processes for preparing crystalline, non-micronized, 3-beta-hydroxy-5-alpha-pregnan-20-one suitable for such suspensions, as well as methods for manufacturing such suspensions.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PERFORMING OPERATIONS</subject><subject>PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SEPARATION</subject><subject>STEROIDS</subject><subject>TRANSPORTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAvLi0uSM0rPrw1tVghMy8rteTwwrLUzGIeBta0xJziVF4ozc2g6uYa4uyhm1qQH59aXJCYnJqXWhLvFGRoaGRgaGlgaGRpauloZEysOgCZ6yVW</recordid><startdate>20191126</startdate><enddate>20191126</enddate><creator>KAROL HORVATH</creator><creator>BJÖRN NORRLIND</creator><creator>MAGNUS BRISANDER</creator><scope>EVB</scope></search><sort><creationdate>20191126</creationdate><title>suspensões injetáveis</title><author>KAROL HORVATH ; BJÖRN NORRLIND ; MAGNUS BRISANDER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112019012959A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PERFORMING OPERATIONS</topic><topic>PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SEPARATION</topic><topic>STEROIDS</topic><topic>TRANSPORTING</topic><toplevel>online_resources</toplevel><creatorcontrib>KAROL HORVATH</creatorcontrib><creatorcontrib>BJÖRN NORRLIND</creatorcontrib><creatorcontrib>MAGNUS BRISANDER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KAROL HORVATH</au><au>BJÖRN NORRLIND</au><au>MAGNUS BRISANDER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>suspensões injetáveis</title><date>2019-11-26</date><risdate>2019</risdate><abstract>a presente invenção refere-se a suspensões assépticas, fisicamente estáveis e injetáveis através de uma agulha de 25g ou mais fina, compreendendo partículas de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalinas, não micronizadas, uma mistura de acilgliceróis e colesterol, processos para a preparação de 3-beta-hidróxi-5-alfa-pregnan-20-ona cristalina, não micronizada, adequada para tais suspensões, assim como métodos para a fabricação de tais suspensões. The present invention relates to aseptic suspensions, physically stable and injectable through a 25 G needle or thinner, comprising crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols and cholesterol, processes for preparing crystalline, non-micronized, 3-beta-hydroxy-5-alpha-pregnan-20-one suitable for such suspensions, as well as methods for manufacturing such suspensions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR112019012959A2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PERFORMING OPERATIONS
PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SEPARATION
STEROIDS
TRANSPORTING
title suspensões injetáveis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T03%3A55%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KAROL%20HORVATH&rft.date=2019-11-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112019012959A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true